Onderzoek naar de optimale duur van de testperiode van behandeling met sacrale neuromodulatie.

• Conditions: overactive bladder (OAB)non-obstructive urinary retention (NOR)sacral neuromodulation (SNM)overactieve blaasniet-obstructieve urine retentiesacrale neuromodulatie

• Registration Number: NL-OMON25907
• Lead Sponsor: Department of Urology,dr. van Koeveringe, urologistMaastricht Universitair Medisch Centrum

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria: Patients should have been diagnosed with overactive bladder syndrome or non-obstructive urinary retention and should be put on the waiting list for scheduling treatment with sacral neuromodulation.

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study: a) patients receiving neurological or psychiatric medication without being diagnosed with a neurological or psychiatric
disease; b) patients who have been treated by means of bladder wall botuline toxine injections in the past twelve months; c) patients with evident subsequent complains of bladder pain syndrome or other pelvic pain.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The transition point between no effect and time of onset is determined by assessing when certain complaints parameters are reduced by 50% compared to baseline per 24 hours. Vice versa (50% increase) for offset of effect. Onset and offset of effect will be assessed in days.

Secondary Outcome Measures

Name	Time	Method
ot applicable.